journal article·2024-10

Tumor Cell Membrane‐Camouflaged Vortex Magnetic Nanoannulars Programmed by Low‐Frequency Magnetic Field: A Novel Anti‐Cancer Delivery System in Triple‐Negative Breast Cancer

Yunshu Lu, Fenfen Gu, Yuwei Ma, Xianhong Da, Ruonan Li, Lan Jiang, Xiang Li, Yan Liu

Advanced Functional Materials· Volume 34· Issue 42
Publisher page

Abstract

Abstract Triple‐negative breast cancer (TNBC), a highly aggressive form of breast cancer, currently lacks targeted therapies and is associated with high recurrence rates in medical practice. In this study, the effectiveness of a specially developed magnetic nanodrug, namely doxorubicin (DOX)‐loaded Fe 3 O 4 vortex magnetic nanoannulars coated with a cancer cell membrane (DOX‐VMAs@CM), against cancer under a varying low‐frequency magnetic field (MF), is investigated. This advanced nanodrug can specifically target and accumulate in tumors. Additionally, it considerably improves tumor suppression compared with that of DOX chemotherapy alone, indicating the possibility of homologous targeting of the cancer cell membrane and the vibrating effect of the MF. The DOX‐VMAs@CM nanoparticles (NPs) exhibit exceptional safety characteristics because of their ability to specifically target tumors. The results of RNA sequencing suggest that the potential mechanisms may involve cellular respiration, cell cycle, and ferroptosis regulation. Altogether, chemotherapy is successfully optimized by implementing a delivery system and MF intervention, and the developed DOX‐VMAs@CM NPs hold significant potential for use in the clinical treatment of TNBC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Micro and Nano Robotics · Molecular Communication and Nanonetworks

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Breast Surgery Shanghai Jiao Tong University School of Medicine Xinhua Hospital Shanghai 200092 China

Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences Shanghai 200093 China

Department of Clinical Pharmacy Shanghai Jiao Tong University School of Medicine Xinhua Hospital Shanghai 200092 China

School of Materials and Chemistry University of Shanghai for Science and Technology Shanghai 200093 China

Clinical Pharmacy Innovation Institute Shanghai Jiao Tong University School of Medicine Shanghai 200092 China

Funding

National Natural Science Foundation of China · Science and Technology Commission of Shanghai Municipality

References (72)

Show source-provided references
1. 10.3322/caac.2176310.3322/caac.21763 ↗
2. 10.1186/s13058-020-01296-510.1186/s13058-020-01296-5 ↗
3. 10.1136/bmj-2022-07167410.1136/bmj-2022-071674 ↗
4. 10.3390/cells809095710.3390/cells8090957 ↗
5. 10.3389/fmolb.2020.0019310.3389/fmolb.2020.00193 ↗
6. 10.1186/s12645-023-00174-x10.1186/s12645-023-00174-x ↗
7. Beck‐Sickinger A. G. · Cancer Biother · 2023 · 38 · 160
8. 10.2174/092986732566617122914115610.2174/0929867325666171229141156 ↗
9. 10.3390/nano904049410.3390/nano9040494 ↗
10. 10.2147/IJN.S3514010.2147/IJN.S35140 ↗
11. 10.1016/j.cmpb.2020.10577810.1016/j.cmpb.2020.105778 ↗
12. 10.1166/jbn.2016.229210.1166/jbn.2016.2292 ↗
13. 10.1021/acs.molpharmaceut.9b0010710.1021/acs.molpharmaceut.9b00107 ↗
14. 10.1002/adma.20140503610.1002/adma.201405036 ↗
15. 10.1038/nmat259110.1038/nmat2591 ↗
16. 10.1038/nrd259110.1038/nrd2591 ↗
17. 10.1021/nn900679710.1021/nn9006797 ↗
18. 10.3390/cancers1506167210.3390/cancers15061672 ↗
19. 10.1021/acs.molpharmaceut.3c0001510.1021/acs.molpharmaceut.3c00015 ↗
20. 10.1016/j.matlet.2021.13135710.1016/j.matlet.2021.131357 ↗
21. 10.1016/j.cej.2019.12301010.1016/j.cej.2019.123010 ↗
22. 10.1039/c0cc05862a10.1039/c0cc05862a ↗
23. 10.1016/j.biomaterials.2021.12095610.1016/j.biomaterials.2021.120956 ↗
24. 10.1021/ja805152t10.1021/ja805152t ↗
25. 10.1088/2053-1591/3/9/09502210.1088/2053-1591/3/9/095022 ↗
26. 10.1016/j.matlet.2020.12892010.1016/j.matlet.2020.128920 ↗
27. 10.1007/s11164-017-3204-010.1007/s11164-017-3204-0 ↗
28. 10.3390/polym1211271610.3390/polym12112716 ↗
29. 10.1021/am505160v10.1021/am505160v ↗
30. 10.1016/j.ceramint.2020.12.07310.1016/j.ceramint.2020.12.073 ↗
31. Yoo J. Y. · Biomed Mater Eng · 2005 · 15 · 279
32. 10.3390/molecules2616505210.3390/molecules26165052 ↗
33. 10.2174/138920021966618091811152810.2174/1389200219666180918111528 ↗
34. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
35. 10.1016/j.nantod.2022.10151210.1016/j.nantod.2022.101512 ↗
36. 10.1002/adhm.20190020310.1002/adhm.201900203 ↗
37. 10.1016/j.biomaterials.2010.06.05110.1016/j.biomaterials.2010.06.051 ↗
38. 10.1016/j.jconrel.2015.07.01910.1016/j.jconrel.2015.07.019 ↗
39. 10.1002/smll.20200648410.1002/smll.202006484 ↗
40. 10.1016/j.ijpharm.2021.12039510.1016/j.ijpharm.2021.120395 ↗
41. 10.1016/j.jcis.2021.02.00610.1016/j.jcis.2021.02.006 ↗
42. 10.3390/pharmaceutics1210095010.3390/pharmaceutics12100950 ↗
43. 10.1016/j.colsurfb.2018.12.03810.1016/j.colsurfb.2018.12.038 ↗
44. 10.1016/j.actbio.2020.01.03610.1016/j.actbio.2020.01.036 ↗
45. 10.1021/acsami.9b2060310.1021/acsami.9b20603 ↗
46. 10.1016/j.jmmm.2016.09.03410.1016/j.jmmm.2016.09.034 ↗
47. 10.1016/j.biomaterials.2016.11.00810.1016/j.biomaterials.2016.11.008 ↗
48. 10.1016/j.cell.2016.12.03910.1016/j.cell.2016.12.039 ↗
49. 10.1126/science.312.5777.115810.1126/science.312.5777.1158 ↗
50. 10.1016/j.chembiol.2021.11.00210.1016/j.chembiol.2021.11.002 ↗
51. 10.3109/15368378.2012.69274810.3109/15368378.2012.692748 ↗
52. 10.1007/s10616-016-9973-210.1007/s10616-016-9973-2 ↗
53. 10.3390/cells1202031510.3390/cells12020315 ↗
54. 10.1093/nar/gkac93510.1093/nar/gkac935 ↗
55. Dai E. · Nat. Cell Biol. · 2024
56. 10.1146/annurev.nutr.24.012003.13221210.1146/annurev.nutr.24.012003.132212 ↗
57. 10.1016/j.cell.2017.09.02110.1016/j.cell.2017.09.021 ↗
58. Chen Y. · Int J Oncol · 2019 · 54 · 1143
59. Pandrangi S. L. · Am. J. Cancer Res. · 2022 · 12 · 974
60. 10.1126/sciadv.aau803810.1126/sciadv.aau8038 ↗
61. 10.1016/j.cell.2022.06.00310.1016/j.cell.2022.06.003 ↗
62. 10.1021/mp800051m10.1021/mp800051m ↗
63. 10.2147/CMAR.S24437410.2147/CMAR.S244374 ↗
64. 10.1039/C3FO60716J10.1039/C3FO60716J ↗
65. 10.1111/cpr.1298610.1111/cpr.12986 ↗
66. 10.1186/1476-4598-12-3010.1186/1476-4598-12-30 ↗
67. 10.1093/bioinformatics/bty56010.1093/bioinformatics/bty560 ↗
68. 10.1038/nmeth.331710.1038/nmeth.3317 ↗
69. 10.1038/nbt.312210.1038/nbt.3122 ↗
70. 10.1186/1471-2105-12-32310.1186/1471-2105-12-323 ↗
71. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
72. 10.1016/j.cej.2023.14388210.1016/j.cej.2023.143882 ↗